Log in to save to my catalogue

Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19

Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2641863867

Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19

About this item

Full title

Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19

Publisher

London: Nature Publishing Group UK

Journal title

Nature (London), 2022-05, Vol.605 (7908), p.146-151

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Coronavirus disease 2019 (COVID-19) is especially severe in aged populations
1
. Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly effective, but vaccine efficacy is partly compromised by the emergence of SARS-CoV-2 variants with enhanced transmissibility
2
. The emergence of these variants emphasi...

Alternative Titles

Full title

Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2641863867

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2641863867

Other Identifiers

ISSN

0028-0836

E-ISSN

1476-4687

DOI

10.1038/s41586-022-04630-3

How to access this item